ID   RB15B_HUMAN             Reviewed;         890 AA.
AC   Q8NDT2; A4QPG7; Q6QE19; Q9BV96;
DT   01-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 3.
DT   28-JUN-2023, entry version 179.
DE   RecName: Full=Putative RNA-binding protein 15B {ECO:0000305};
DE   AltName: Full=One-twenty two protein 3 {ECO:0000303|PubMed:16129689, ECO:0000303|PubMed:19586903};
DE            Short=HsOTT3 {ECO:0000303|PubMed:19586903};
DE            Short=HuOTT3 {ECO:0000303|PubMed:16129689};
DE   AltName: Full=RNA-binding motif protein 15B {ECO:0000303|PubMed:19586903};
GN   Name=RBM15B {ECO:0000303|PubMed:16129689, ECO:0000303|PubMed:19586903,
GN   ECO:0000312|HGNC:HGNC:24303};
GN   Synonyms=OTT3 {ECO:0000303|PubMed:16129689,
GN   ECO:0000303|PubMed:19586903};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 155-890 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 633-780.
RC   TISSUE=Head;
RA   Sales M.M., Ferrasi A.C., Pereira A.A., Pardini M.I.M.C., Camargo A.A.;
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, INTERACTION WITH EPSTEIN-BARR VIRUS BMLF1 (MICROBIAL INFECTION)
RP   AND NCOR2, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16129689; DOI=10.1074/jbc.m501725200;
RA   Hiriart E., Gruffat H., Buisson M., Mikaelian I., Keppler S., Meresse P.,
RA   Mercher T., Bernard O.A., Sergeant A., Manet E.;
RT   "Interaction of the Epstein-Barr virus mRNA export factor EB2 with human
RT   Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links
RT   Spen proteins with splicing regulation and mRNA export.";
RL   J. Biol. Chem. 280:36935-36945(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH ALYREF AND NXF1.
RX   PubMed=19586903; DOI=10.1074/jbc.m109.040113;
RA   Uranishi H., Zolotukhin A.S., Lindtner S., Warming S., Zhang G.M., Bear J.,
RA   Copeland N.G., Jenkins N.A., Pavlakis G.N., Felber B.K.;
RT   "The RNA-binding motif protein 15B (RBM15B/OTT3) acts as cofactor of the
RT   nuclear export receptor NXF1.";
RL   J. Biol. Chem. 284:26106-26116(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109 AND SER-552, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   FUNCTION.
RX   PubMed=21044963; DOI=10.1074/jbc.m110.192518;
RA   Loyer P., Busson A., Trembley J.H., Hyle J., Grenet J., Zhao W.,
RA   Ribault C., Montier T., Kidd V.J., Lahti J.M.;
RT   "The RNA binding motif protein 15B (RBM15B/OTT3) is a functional competitor
RT   of serine-arginine (SR) proteins and antagonizes the positive effect of the
RT   CDK11p110-cyclin L2alpha complex on splicing.";
RL   J. Biol. Chem. 286:147-159(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109; SER-552 AND SER-562, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-532; SER-556 AND SER-562, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-109, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-213 AND LYS-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [18]
RP   FUNCTION, RNA-BINDING, AND IDENTIFICATION IN THE WMM COMPLEX.
RX   PubMed=27602518; DOI=10.1038/nature19342;
RA   Patil D.P., Chen C.K., Pickering B.F., Chow A., Jackson C., Guttman M.,
RA   Jaffrey S.R.;
RT   "m(6)A RNA methylation promotes XIST-mediated transcriptional repression.";
RL   Nature 537:369-373(2016).
CC   -!- FUNCTION: RNA-binding protein that acts as a key regulator of N6-
CC       methyladenosine (m6A) methylation of RNAs, thereby regulating different
CC       processes, such as alternative splicing of mRNAs and X chromosome
CC       inactivation mediated by Xist RNA (PubMed:16129689, PubMed:27602518).
CC       Associated component of the WMM complex, a complex that mediates N6-
CC       methyladenosine (m6A) methylation of RNAs, a modification that plays a
CC       role in the efficiency of mRNA splicing and RNA processing
CC       (PubMed:27602518). Plays a key role in m6A methylation, possibly by
CC       binding target RNAs and recruiting the WMM complex (PubMed:27602518).
CC       Involved in random X inactivation mediated by Xist RNA: acts by binding
CC       Xist RNA and recruiting the WMM complex, which mediates m6A
CC       methylation, leading to target YTHDC1 reader on Xist RNA and promoting
CC       transcription repression activity of Xist (PubMed:27602518). Functions
CC       in the regulation of alternative or illicit splicing, possibly by
CC       regulating m6A methylation (PubMed:16129689). Inhibits pre-mRNA
CC       splicing (PubMed:21044963). Also functions as a mRNA export factor by
CC       acting as a cofactor for the nuclear export receptor NXF1
CC       (PubMed:19586903). {ECO:0000269|PubMed:19586903,
CC       ECO:0000269|PubMed:21044963, ECO:0000269|PubMed:27602518,
CC       ECO:0000305|PubMed:16129689}.
CC   -!- SUBUNIT: Component of the WMM complex, a N6-methyltransferase complex
CC       composed of a catalytic subcomplex, named MAC, and of an associated
CC       subcomplex, named MACOM (PubMed:27602518). The MAC subcomplex is
CC       composed of METTL3 and METTL14 (PubMed:27602518). The MACOM subcomplex
CC       is composed of WTAP, ZC3H13, CBLL1/HAKAI, VIRMA, and, in some cases of
CC       RBM15 (RBM15 or RBM15B) (PubMed:27602518). May interact with NCOR2
CC       (PubMed:16129689). Interacts with NXF1, the interaction is required to
CC       promote mRNA export (PubMed:19586903). {ECO:0000269|PubMed:16129689,
CC       ECO:0000269|PubMed:19586903, ECO:0000269|PubMed:27602518}.
CC   -!- SUBUNIT: (Microbial infection) Interacts (via the SPOC domain) with
CC       Epstein-Barr virus BMLF1 (via the N-terminus); the interaction is
CC       direct. {ECO:0000269|PubMed:16129689}.
CC   -!- INTERACTION:
CC       Q8NDT2; Q8IVL1: NAV2; NbExp=3; IntAct=EBI-726721, EBI-741200;
CC       Q8NDT2-2; Q9UJX2: CDC23; NbExp=3; IntAct=EBI-10269922, EBI-396137;
CC       Q8NDT2-2; Q92997: DVL3; NbExp=3; IntAct=EBI-10269922, EBI-739789;
CC       Q8NDT2-2; Q8IVL1: NAV2; NbExp=3; IntAct=EBI-10269922, EBI-741200;
CC       Q8NDT2-2; O76024: WFS1; NbExp=3; IntAct=EBI-10269922, EBI-720609;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:16129689}. Nucleus speckle
CC       {ECO:0000269|PubMed:19586903}. Nucleus envelope
CC       {ECO:0000269|PubMed:19586903}. Note=Colocalizes with BMLF1 in the
CC       nucleus. Localized in the nucleoplasm with a granular staining pattern
CC       and excluded from the nucleoli. {ECO:0000269|PubMed:16129689}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NDT2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NDT2-2; Sequence=VSP_053878;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:16129689}.
CC   -!- SIMILARITY: Belongs to the RRM Spen family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH01367.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAS50153.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the C-terminal part.; Evidence={ECO:0000305};
CC       Sequence=CAD38547.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC092037; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001367; AAH01367.2; ALT_INIT; mRNA.
DR   EMBL; BC139836; AAI39837.1; -; mRNA.
DR   EMBL; AL831838; CAD38547.2; ALT_INIT; mRNA.
DR   EMBL; AY545557; AAS50153.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS33764.1; -. [Q8NDT2-1]
DR   RefSeq; NP_037418.3; NM_013286.4. [Q8NDT2-1]
DR   AlphaFoldDB; Q8NDT2; -.
DR   SMR; Q8NDT2; -.
DR   BioGRID; 118943; 95.
DR   IntAct; Q8NDT2; 41.
DR   MINT; Q8NDT2; -.
DR   STRING; 9606.ENSP00000454545; -.
DR   GlyGen; Q8NDT2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8NDT2; -.
DR   PhosphoSitePlus; Q8NDT2; -.
DR   BioMuta; RBM15B; -.
DR   DMDM; 229463030; -.
DR   EPD; Q8NDT2; -.
DR   jPOST; Q8NDT2; -.
DR   MassIVE; Q8NDT2; -.
DR   MaxQB; Q8NDT2; -.
DR   PaxDb; Q8NDT2; -.
DR   PeptideAtlas; Q8NDT2; -.
DR   ProteomicsDB; 73053; -. [Q8NDT2-1]
DR   Antibodypedia; 59712; 74 antibodies from 18 providers.
DR   DNASU; 29890; -.
DR   Ensembl; ENST00000563281.2; ENSP00000454545.1; ENSG00000259956.2. [Q8NDT2-1]
DR   GeneID; 29890; -.
DR   KEGG; hsa:29890; -.
DR   MANE-Select; ENST00000563281.2; ENSP00000454545.1; NM_013286.5; NP_037418.3.
DR   UCSC; uc003dbd.4; human. [Q8NDT2-1]
DR   AGR; HGNC:24303; -.
DR   CTD; 29890; -.
DR   DisGeNET; 29890; -.
DR   GeneCards; RBM15B; -.
DR   HGNC; HGNC:24303; RBM15B.
DR   HPA; ENSG00000259956; Low tissue specificity.
DR   MIM; 612602; gene.
DR   neXtProt; NX_Q8NDT2; -.
DR   OpenTargets; ENSG00000259956; -.
DR   PharmGKB; PA134870079; -.
DR   VEuPathDB; HostDB:ENSG00000259956; -.
DR   eggNOG; KOG0112; Eukaryota.
DR   GeneTree; ENSGT00940000160561; -.
DR   HOGENOM; CLU_012724_1_0_1; -.
DR   InParanoid; Q8NDT2; -.
DR   OMA; NFRHPGD; -.
DR   OrthoDB; 2873387at2759; -.
DR   PhylomeDB; Q8NDT2; -.
DR   TreeFam; TF354224; -.
DR   PathwayCommons; Q8NDT2; -.
DR   SignaLink; Q8NDT2; -.
DR   BioGRID-ORCS; 29890; 12 hits in 1153 CRISPR screens.
DR   ChiTaRS; RBM15B; human.
DR   GenomeRNAi; 29890; -.
DR   Pharos; Q8NDT2; Tbio.
DR   PRO; PR:Q8NDT2; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8NDT2; protein.
DR   Bgee; ENSG00000259956; Expressed in ganglionic eminence and 189 other tissues.
DR   Genevisible; Q8NDT2; HS.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0036396; C:RNA N6-methyladenosine methyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0009048; P:dosage compensation by inactivation of X chromosome; IDA:UniProtKB.
DR   GO; GO:0006406; P:mRNA export from nucleus; ISS:UniProtKB.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0001510; P:RNA methylation; IDA:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IEA:UniProtKB-KW.
DR   CDD; cd12554; RRM1_RBM15B; 1.
DR   CDD; cd12556; RRM2_RBM15B; 1.
DR   CDD; cd12558; RRM3_RBM15B; 1.
DR   CDD; cd21550; SPOC_RBM15B; 1.
DR   Gene3D; 2.40.290.10; -; 1.
DR   Gene3D; 3.30.70.330; -; 3.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR034475; RBM15B_RRM1.
DR   InterPro; IPR034535; RBM15B_RRM2.
DR   InterPro; IPR034536; RBM15B_RRM3.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR016194; SPOC-like_C_dom_sf.
DR   InterPro; IPR012921; SPOC_C.
DR   InterPro; IPR010912; SPOC_met.
DR   PANTHER; PTHR23189; RNA RECOGNITION MOTIF-CONTAINING; 1.
DR   PANTHER; PTHR23189:SF40; RNA-BINDING PROTEIN 15B-RELATED; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   Pfam; PF07744; SPOC; 1.
DR   SMART; SM00360; RRM; 3.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 2.
DR   SUPFAM; SSF100939; SPOC domain-like; 1.
DR   PROSITE; PS50102; RRM; 3.
DR   PROSITE; PS50917; SPOC; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Host-virus interaction; Isopeptide bond;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..890
FT                   /note="Putative RNA-binding protein 15B"
FT                   /id="PRO_0000081778"
FT   DOMAIN          139..219
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          337..414
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          418..492
FT                   /note="RRM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          711..889
FT                   /note="SPOC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00249"
FT   REGION          1..133
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          219..253
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          547..705
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          722..890
FT                   /note="Interaction with Epstein-Barr virus BMLF1"
FT   MOTIF           593..597
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        19..36
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        110..127
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        561..620
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        627..644
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        658..705
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         109
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:24275569"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PHZ5"
FT   MOD_RES         265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6PHZ5"
FT   MOD_RES         267
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         532
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         552
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         556
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   CROSSLNK        213
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        702
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..327
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_053878"
FT   CONFLICT        593
FT                   /note="R -> K (in Ref. 2; AAI39837)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   890 AA;  97205 MW;  276C94252F036C83 CRC64;
     MKRQSERDSS PSGRGSSSSA KRPREREREA EAGGRRAAHK ASGGAKHPVP ARARDKPRGS
     GSGGGGHRDG RGTGDANHRA SSGRSSGSGA GGGGRGGKAS GDPGASGMSP RASPLPPPPP
     PPGAEPACPG SSAAAPEYKT LLISSLSPAL PAEHLEDRLF HQFKRFGEIS LRLSHTPELG
     RVAYVNFRHP QDAREARQHA LARQLLLYDR PLKVEPVYLR GGGGSSRRSS SSSAAASTPP
     PGPPAPADPL GYLPLHGGYQ YKQRSLSPVA APPLREPRAR HAAAAFALDA AAAAAVGLSR
     ERALDYYGLY DDRGRPYGYP AVCEEDLMPE DDQRATRNLF IGNLDHSVSE VELRRAFEKY
     GIIEEVVIKR PARGQGGAYA FLKFQNLDMA HRAKVAMSGR VIGRNPIKIG YGKANPTTRL
     WVGGLGPNTS LAALAREFDR FGSIRTIDHV KGDSFAYIQY ESLDAAQAAC AKMRGFPLGG
     PDRRLRVDFA KAEETRYPQQ YQPSPLPVHY ELLTDGYTRH RNLDADLVRD RTPPHLLYSD
     RDRTFLEGDW TSPSKSSDRR NSLEGYSRSV RSRSGERWGA DGDRGLPKPW EERRKRRSLS
     SDRGRTTHSP YEERSRTKGS GQQSERGSDR TPERSRKENH SSEGTKESSS NSLSNSRHGA
     EERGHHHHHH EAADSSHGKK ARDSERNHRT TEAEPKPLEE PKHETKKLKN LSEYAQTLQL
     GWNGLLVLKN SCFPTSMHIL EGDQGVISSL LKDHTSGSKL TQLKIAQRLR LDQPKLDEVT
     RRIKQGSPNG YAVLLATQAT PSGLGTEGMP TVEPGLQRRL LRNLVSYLKQ KQAAGVISLP
     VGGSKGRDGT GMLYAFPPCD FSQQYLQSAL RTLGKLEEEH MVIVIVRDTA
//
